Gianluca Gragnano - Publications

Next-generation sequencing using a targeted gene panel in advanced solid tumors: five years of experience from an Italian referral institution.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 08, 2026

Analytical reliability of cell-free DNA from fine-needle aspiration rinses for BRAF and NRAS testing in metastatic melanoma.

Journal: Journal of the American Society of Cytopathology

Published: November 28, 2025

Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience.

Journal: The journal of liquid biopsy

Published: July 04, 2025

Economic assessment of NGS testing workflow for NSCLC in a healthcare setting.

Journal: Heliyon

Published: February 06, 2024

NGAL Mediates Anaplastic Thyroid Carcinoma Cells Survival Through FAS/CD95 Inhibition.

Journal: Endocrinology

Published: September 20, 2023

Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution.

Journal: The journal of liquid biopsy

Published: July 17, 2023

An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples.

Journal: Diagnostics (Basel, Switzerland)

Published: November 11, 2022

Methods for actionable gene fusion detection in lung cancer: now and in the future.

Journal: Pharmacogenomics

Published: September 16, 2021

Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting.

Journal: Cells

Published: May 25, 2021

Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021.

Journal: Critical reviews in oncology/hematology

Published: March 09, 2021

Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study.

Journal: Journal of clinical pathology

Published: March 01, 2021

Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer.

Journal: Journal of clinical pathology

Published: January 13, 2021